Summary:
In this segment, the speaker discusses how AI is revolutionizing the drug repurposing process. Previously, drug repurposing was limited by manual research on individual diseases and drugs. With AI, scientists can now analyze a vast array of drugs and diseases simultaneously, generating a ranking system based on the likelihood of success. The Center for Cytokine Storm Treatment and Laboratory, along with the platform Every Cure, uses AI to score 3000 drugs against 18,000 diseases. This platform dramatically reduces the time and resources required for drug repurposing, enabling predictions that can be tested in a fraction of the time.
Key Takeaways:
AI is accelerating the drug repurposing process, offering faster and more comprehensive analysis of possible drug-disease matches.
The AI-based platform assigns a likelihood score to each potential match, streamlining the process for testing and validation.
Our Editors Also Recommend:
AI’s Drug Revolution, Part 1: Faster Trials and Approvals
From AI to Obesity Drugs to Soaring Costs: Medscape Hot Topics in the Medical Profession Report 2024
AI Voice Analysis for Diabetes Screening Shows Promise
To see the full event recording, click here.
A version of this article appeared on Medscape.com.